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Abstract
Objective: Clot characteristics can provide information on the cause of cerebral
artery occlusion and may guide acute revascularization and secondary prevention
strategies. We developed a rapid automated clot analysis system using machine
learning (ML) and validated its accuracy in patients undergoing endovascular
treatment. Methods: Pre-endovascular treatment gradient echo (GRE) images
from consecutive patients with middle cerebral artery occlusion were utilized to
develop and validate an ML system to predict whether atrial fibrillation (AF) was
the underlying cause of ischemic stroke. The accuracy of the ML algorithm was
compared with that of visual inspection by neuroimaging specialists for the pres-
ence of blooming artifact. Endovascular procedures and outcomes were com-
pared in patients with and without AF. Results: Of 67 patients, 29 (43.3%) had
AF. Of these, 13 had known AF and 16 were newly diagnosed with cardiac moni-
toring. By visual inspection, interrater correlation for blooming artifact was 0.73
and sensitivity and specificity for AF were 0.79 and 0.63, respectively. For AF clas-
sification, the ML algorithms yielded an average accuracy of > 75.4% in fivefold
cross-validation with clot signal profiles obtained from 52 patients and an area
under the curve >0.87 for the average AF probability from five signal profiles in
external validation (n = 15). Analysis with an in-house interface took approxi-
mately 3 min per patient. Absence of AF was associated with increased number of
passes by stentriever, high reocclusion frequency, and additional use of rescue
stenting and/or glycogen IIb/IIIa blocker for recanalization. Interpretation: ML-
based rapid clot analysis is feasible and can identify AF with high accuracy,
enabling selection of endovascular treatment strategy.
Introduction
Neuroimaging in acute ischemic stroke plays an impor-
tant role in selecting candidates for revascularization ther-
apy based on the distribution and extent of infarct core,
collateral, penumbra, and blood–brain barrier, and in
determining the mode of treatment based on clot charac-
teristics.1 Identifying the characteristics of clots blocking
brain vessels in acute ischemic stroke may provide impor-
tant information in determining strategies of revascular-
ization therapy as well as in choosing antithrombotics for
secondary prevention of stroke.2 Knowledge of clot char-
acteristics may help predict the recanalization rate, time
required for re-opening, and optimal mode of treatment.3
In addition, the effects of antiplatelet agents and anticoag-
ulants differ depending on the stroke subtype.4
As machine learning (ML), more specifically deep
learning, shows remarkable performance in computer
vision as well as in medical image analysis,5 it is increas-
ingly being used in acute stroke neuroimaging.6,7 For
example, segmentation of infarct core and penumbra with
ML algorithms demonstrated high accuracy compared to
experts’ manual annotations or commercial software.8–10
The accurate identification of diffusion and perfusion
lesions helps select patients eligible for endovascular treat-
ment (EVT). The estimation of infarct core and
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penumbra is related to the development of learning mod-
els in predicting final infarct distribution or patient out-
come in cases of favorable and unfavorable responses to
reperfusion therapy.11–13 Another ML application is the
prediction of risks of hemorrhagic transformation from
image data with blood–brain barrier information.14 The
ML-based prediction of hemorrhagic transformation may
serve as a decision support tool for reperfusion therapy.
Finally, ML was applied to the task of selecting patients
less than 4.5 hours from stroke onset.15,16 This may be
particularly helpful in selecting patients with unknown
onset to imaging time for intravenous thrombolysis.
Previous studies have indicated that vessel signs from
noncontrast computed tomography (CT) and gradient-
echo (GRE) magnetic resonance imaging (MRI) help
elucidate clot composition in acute ischemic stroke.17–19
Hyperdense artery sign in CT or blooming artifact in MRI
is associated with red blood cell (RBC)-rich clots.20,21
Image features such as two-layered susceptibility vessel sign
(SVS), overestimation ratio, and SVS diameter have been
demonstrated to be effective in predicting cardioembolic
stroke.3,22,23 In the previous literature, two-layered SVS
was assessed by visual inspection, and the quantification of
overestimation ratio and SVS diameter relied on manual
procedures by expert neurologists. The use of ML-based
pattern recognition in clot characterization may be advan-
tageous, since the decision making can be automated and
the issue of intra and interrater variability can be alleviated.
This study investigated the feasibility of analyzing clot
characteristics using GRE MRI and ML, with the expecta-
tion that ML could provide reliable assessment of clot
characteristics. In addition, the clinical impact of ML-
based MRI clot analysis on endovascular procedures and
outcomes was considered in patients who received
endovascular treatment.
Methods
Patients and work-ups
This study included patients who were admitted to a uni-
versity medical center and underwent EVT between April
1, 2014 and February 31, 2017. The study inclusion
criteria were as follows: (1) middle cerebral artery (MCA)
occlusion, (2) MRI including gradient echo (GRE) sequence
performed prior to EVT, and (3) EVT within 12 h of
symptom onset. Patients with poor GRE image quality due
to motion artifact were excluded.
Demographic information, history of vascular risk factors,
and initial National Institutes of Health Stroke Scale
(NIHSS) scores were systematically collected. Radiologic
information (time interval from symptom onset to MRI)
and stroke treatment information (intravenous tissue
plasminogen activator, onset to initiation of EVT, and dura-
tion of EVT) were obtained by reviewing electronic medical
records. We performed standard cardiac source evaluation,
including multiple electrocardiograms, transthoracic or
transesophageal echocardiography, 24-h Holter monitoring,
and cardiac telemetry (72 h or more).24 Local institutional
review boards approved this study. All participants or
patient guardians provided informed consent.
Visual inspection of blooming artifact
Based on visual inspection, the presence or absence of
blooming artifact was scored by two neuroimaging
experts, who were experienced in stroke MRI reading
and blinded to clinical information. For each subject’s
data, each rater navigates the axial slices and identifies a
slice showing MCA. When MCA was captured in more
than one slice, the slice with larger MCA was chosen for
scoring. Blooming artifact was defined as an area of
hypointensity or signal loss in the proximal MCA, dis-
torting the margins of the vessel with enlargement of
vessel contour. The raters re-scored presence of bloom-
ing artifact 2 weeks later to estimate interobserver vari-
ability. The interrater agreement for the measurement of
blooming artifact was assessed using the Kappa statistics
and 95% confidence interval. The results of visual
inspection and presence of atrial fibrillation were
analyzed.
Region of interest allocation and extraction
of signal graphic information
MRI data were acquired on a 3T scanner system (Philips
Achieva, Best, The Netherlands) using a gradient-echo
(GRE) sequence with slice thickness = 5 mm, interslice
gap = 1.5 mm, TR = 610 msec, TE = 16 msec, flip
angle = 18°, field of view = 240 mm, acquisition matrix
size = 256 9 249, and reconstruction matrix size = 560
9 560. The GRE images were normalized to [0, 1] to
reduce the effect of the image intensity variability in the
subjects. Figure 1D and E shows our in-house graphical
user interface (GUI) developed in MATLAB (Mathworks,
Natick, MA, USA). Procedures for GUI usage are described
as follows. For each subject’s data, a user navigates the axial
slices and identifies a region of interest (ROI) indicating
blooming artifact in the MCA. When MCA was captured
in more than one slice, the slice with larger MCA was cho-
sen for evaluation. The start and end points are clicked by
the user; then, a centerline connecting the two points is
drawn and covers the clot ROI automatically. When the
start and end points are determined, 30-pixel-wide lines
are drawn to be parallel to each other and perpendicular to
the centerline. A line profile plot is obtained from the
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intensity values on each line. Each line profile served as fea-
ture input to a machine learning classifier model. Figure 1
shows representative ROI images and associated intensity
profiles for clot in patients with atrial fibrillation (Fig. 1A)
and without atrial fibrillation (Fig. 1B). The procedures
were semiautomatic and took approximately 3 min per
patient from loading of the GRE DICOM images in the
GUI until machine learning prediction of the AF clot
characteristics.
Development of supervised machine
learning model
Step 1. Model development
For ML model, individual patient’s GRE images were
included. The model did not include any clinical data in
order for the model to be performed without any addi-
tional manual entering of variables. Training data were
obtained from 52 subjects (n = 22 for atrial fibrillation,
n = 30 for nonatrial fibrillation). For each subject, samples
of the number of line profiles 9 30 vectors were obtained
after specification of the start and end points in a clot ROI.
We augmented the number of samples twice by horizon-
tally flipping each intensity profile. The dimensions of (# of
samples) 9 (# of features) in the training dataset were
2048 9 30, which was the input to the ML model. The
2048 samples consisted of 920 AF samples and 1128 non-
AF samples. Figure 1C displays the flow chart of our
ML-based clot characterization framework. For compar-
ison, we tested random forests, support vector machine,
artificial neural network, and logistic regression algorithms
since these four models have distinct characteristics in
model training and are widely used for classification.25
Step 2. Model validation
With the training dataset, fivefold cross-validation was
performed to evaluate the performance of the four ML
models. The cross-validation folds were constructed based
on the patient, rather than based on the intensity profile.
The fold 1,2, and 3 each contained the intensity profiles
from 4 AF and 6 non-AF patients, whereas the fold 4 and
Figure 1. Basic scheme of machine learning-based clot analysis. (A, B) The red circles indicate user-marked start and end points of clot ROI. The
five red lines were located vertical to user-marked clot location at even intervals and were used to extract signal intensities for graphic analysis.
(A, Clot related to atrial fibrillation; B, Clot unrelated to atrial fibrillation). (C) Flowchart of the proposed ML-based clot characterization method,
where T is the threshold for Afib/non-Afib classification. (D, E) Custom GUI for clot analysis. ROI, region of interest; GUI, graphical user interface;
Afib, atrial fibrillation; ML, machine learning; T, threshold.
ª 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association. 741
J.-W. Chung et al. Machine Learning for Clot Analysis
5 each had the intensity profiles from 5 AF and 6 non-AF
patients. The assignment of the patients to each fold was
performed in a random manner. The ML models of ran-
dom forests, support vector machine, artificial neural net-
work, and logistic regression, provided by the Python’s
scikit-learn package were used for cross-validation.26 After
hyperparameter selection of each model using grid search,
mean and standard deviation of the cross-validation accu-
racy were computed for each model.
For external validation, we used GRE images from 15
unseen subjects, who arrived at the hospital in the later
period (n = 7 for atrial fibrillation, n = 8 for nonatrial
fibrillation), and tested the performance of the binary clas-
sification of clot characteristics. The GRE image protocol
and clinical evaluation methods for detection of atrial fib-
rillation in the development and validation groups were
identical in this study. For each subject, users identified the
clot ROI and clicked the start and end points. Five perpen-
dicular line profiles were automatically drawn as shown in
Figure 1E. There are other choices in the number of line
profiles, but empirically 5 per clot ROI was the reasonable
number of line profiles based on the lengths of visually evi-
dent clots in all the subjects considered. Each line profile
was fed to the trained ML model. A probability of AF clot
was obtained as a result of the classifier, except for the sup-
port vector machine which produced binary values 0 or 1
as output. For the clot ROI of interest, final average atrial
fibrillation probability (PAF,avg) was obtained after averag-
ing of the five predicted AF probabilities. A receiver operat-
ing characteristic (ROC) curve was plotted to evaluate the
model’s prediction performance at various settings of the
PAF,avg thresholds. In the clot analysis GUI, the threshold
“T” in Figure 1C was determined to meet a proper trade-
off between sensitivity and specificity. The value of thresh-
old “T” in the GUI can be used for binary decision of AF/
non-AF.
Statistical analysis
Descriptive demographics and clinical and radiological
data are shown as mean  standard deviations or num-
bers and frequencies, as appropriate. We analyzed the dif-
ferences among the groups using chi-square or Mann–
Whitney tests for discrete variables and one-way analysis
of variance or Kruskal–Wallis tests for continuous
variables. Sensitivity and specificity were compared in
between visual inspection and machine learning-based
clot analysis for underlying atrial fibrillation.
Results
Of 129 consecutive patients treated with EVT during the
study period, 81 were diagnosed with stroke caused by an
MCA occlusion. After excluding 10 patients who did not
have GRE MRI prior to EVT or whose GRE image quality
was inadequate for analysis, and 4 with no visible MCA on
GRE imaging, a total of 67 were included in the final analy-
sis. Among these 67 eligible patients, 41 (61.2%) were male,
with a mean age of 61.7  16.2 years, and 29 (43.3%) had
atrial fibrillation; of these, 13 (44.8%) had known atrial fib-
rillation and 16 (55.2%) were newly diagnosed with pro-
longed cardiac monitoring. Median onset to GRE imaging
time was 120 min (interquartile range, 99–185), and med-
ian onset to groin puncture was 183 min (interquartile
range, 146–230). Comparisons of demographic, clinical,
laboratory, and treatment profiles of the study subjects
according to the absence or presence of atrial fibrillation
are summarized in Table 1. Inter and intrarater agreement
for blooming artifact was poor; (1) Interrater agreement
Kappa, 0.73; 95% confidence interval, 0.60–0.83, (2)
Intrarater agreement #1 agreement Kappa, 0.70; 95% confi-
dence interval, 0.47–0.94, (3) Intrarater agreement #1
agreement Kappa, 0.73; 95% confidence interval, 0.65–0.88.
The discordant cases were re-reviewed and final bloom-
ing artifact was determined by consensus. The sensitivity
and specificity for underlying atrial fibrillation were 0.79
and 0.63, respectively (area under the curve, 0.78). For
the ML classification techniques, the fivefold cross-valida-
tion resulted in mean accuracy (standard deviation) of
75.4 (7.7) % for random forest, 78.7 (9.4) % for sup-
port vector machine, 75.5 (10.4) % for artificial neural
network, and 77.3 (9.4) % for logistic regression,
respectively. The external validation resulted in the areas
under the curve of 0.87–0.93 and 0.91–0.93 for observer 1
and observer 2, respectively (Fig. 2).
Among the 67 patients, 55 (82.1%) were treated with sten-
triever-based endovascular procedures. Compared to patients
with atrial fibrillation, more retrieval passes (3 [3–4] vs.
2 [1–3], P < 0.001) and more frequent reocclusion (2 [0–4]
vs. 0 [0–0], P < 0.001) were observed in patients without
atrial fibrillation. Using a stentriever, successful recanalization
(modified Treatment in Cerebral Infarction ≥ 2b) was
achieved in 2 (7.9%) patients without atrial fibrillation and
19 (65.5%) with atrial fibrillation (P < 0.001). Additional
recanalization was achieved with MCA stenting or intraarte-
rial glycogen IIb/IIIa blocker infusion in 13 (34.2%) patients
without atrial fibrillation and 2 (3.8%) with atrial fibrillation.
The details of EVT according to clot characteristics are sum-
marized in Table 2. Representative cases of clot analysis in
atrial fibrillation and intracranial atherosclerotic occlusion
are presented in Figure 3.
Discussion
The major findings of this study were as follows. In
patient with acute MCA occlusion, pretreatment GRE
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image-based clot analysis was feasible, and a machine
learning-based clot analysis algorithm predicted atrial fib-
rillation with high accuracy. Response to EVT and the
need for therapy differed between patients with and with-
out atrial fibrillation as well as according to the character-
istics of clot imaging. This suggests that utilization of a
machine learning algorithm for evaluation of clot charac-
teristics based on GRE imaging could be helpful in select-
ing an appropriate EVT modality and may lead to faster
recanalization in patients with MCA occlusion.
There have been efforts to visualize the clot in patients
with acute ischemic stroke. Clot characteristics can be
Table 1. Baseline characteristics according to presence of atrial fibrillation.
Without atrial fibrillation (n = 38) With atrial fibrillation (n = 29) P-value
Age (year), mean  SD 56.5  17.8 68.4  10.8 0.002
Male sex, n (%) 26 (68.4) 15 (51.7) 0.165
Hypertension, n (%) 19 (50.0) 15 (51.4) 0.889
Diabetes, n (%) 7 (18.4) 8 (27.6) 0.373
Dyslipidemia, n (%) 5 (13.2) 6 (20.7) 0.41
Atrial fibrillation, n (%) NA
Previously diagnosed 0 (0.0) 13 (44.8)
Newly detected 0 (0.0) 16 (55.2)
Other causes of clot NA
Intracranial atherosclerosis 24 (63.2) 0 (0.0)
Thromboembolism from carotid plaque 6 (15.8) 0 (0.0)
Other and undetermined sources1 8 (21.0) 0 (0.0)
Initial NIHSS score 12 [9–16] 15 [12–18] 0.038
Intravenous tPA, n (%) 23 (60.5) 22 (75.9) 0.185
Glucose (mg/mL), mean  SD 133.2  42.7 118.0  20.7 0.083
Systolic blood pressure (mmHg), mean  SD 139.7  21.6 140.9  17.6 0.814
Symptom to ER arrival, median (IQR) 53 [28–98] 45 [31–123] 0.537
Symptom to GRE imaging, median (IQR) 124 [94–183] 116 [101–187] 0.368
Symptom to groin puncture (min), median (IQR) 190 [145–227] 180 [157–240] 0.502
SD, standard deviation; tPA, NIHSS, National Institutes of Health stroke scale; Tissue plasminogen activator; ER, emergency room; IQR, interquartile
range; GRE, gradient echo.
1Paradoxical embolism in 2, aortic arch atheroma in 1, and undetermined source in 5.
Figure 2. ROC curves for external validation (n = 15) in classification of AF and non-AF clots. For each patient, two testers blinded to clinical
information evaluated the classification of AF and non-AF clots in the custom GUI, by taking the five intensity profiles in a clot ROI as input to
four different machine learning classifiers. ROC, receiver operating characteristic; RF, random forests; SVM, support vector machine; NN, neural
network; LR, logistic regression.
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expressed by the length/burden and composition, which
may be related to etiopathologic subtypes of stroke. The
importance of clot burden in intravenous thrombolysis
has been evaluated with computed tomography (CT) and
MR angiography.27–29 Recent studies attempted to mea-
sure clot burden using clot volume and length with non-
contrast CT or CT angiography. However, conflicting
results have been reported for the association with suc-
cessful endovascular recanalization,30 and results from
recent randomized clinical trials showed that clot burden
score did not modify the effects of EVT.31,32 In addition,
thin (e.g., 1 mm) scan thickness and software for post-
processing was required to measure clot volume and
length using CT images, which may not be practical in
the setting of EVT for acute ischemic stroke. In addition,
successful reperfusion could be associated with the
histopathology of occlusive thrombi, including the exis-
tence of atheromatous gruel and proportion of erythro-
cyte components.33 Although there have been efforts to
predict the response to revascularization therapy using
CT clot imaging, a recent systematic analysis showed a
lack of association between CT-based clot image (e.g.,
Hounsfield units) and the histopathology of thrombi or
stroke etiology.20
MRI can identify clot with high specificity and can
measure clot burden more clearly than CT images.34–36
Blooming artifact, caused by paramagnetic materials, in
GRE or susceptible weighted images has been associated
with cardioembolic stroke.3,23 Compared to large artery
atherosclerosis, clot with atheromatous plaque, deoxyhe-
moglobin, and hemosiderin in the erythrocyte can cause a
paramagnetic blooming effect. In a pathology study with
thrombi retrieved via EVT, blooming artifact appearance
was determined by the presence of red blood cells, and
their absence indicated fibrin-predominant occlusive
thrombi.17 The limitation of brain MRI including GRE
imaging requires longer scan time compared to CT.
Although a comprehensive MRI protocol can be per-
formed in 20 min, a fast MRI protocol can be performed
in 6 min, rivaling that of any comprehensive acute stroke
CT protocol.37 This fast MRI protocol includes diffusion
weighted imaging, fluid attenuated inversion recovery,
GRE, MR angiography, and MR perfusion. We used a
modified protocol that required a 9-min scanning time in
candidates for EVT.38 An additional 3 min were required
for postprocessing and machine learning-based etiologic
prediction of clot with GRE imaging. The 12-min proto-
col might be acceptable considering that decision making
with trial-and-error for stentriever failure often requires
tens of minutes or even hours.
Machine learning technique may help to increase inter-
rater reliability in interpreting stroke imaging data. For
example, Alberta Stroke Program Early CT score
(e-ASPECT) software automatically generates a score
from brain CT, and proved to be effective with a high
degree of reliability in calculating the score compared to
that calculated by a stroke physician and neuroradiolo-
gist.39,40 This study showed that compared to simple
visual analysis of blooming effect by neuroimaging
experts, machine learning technique increased interrater
reliability, and overall reliability in terms of predicting
atrial fibrillation with clot analysis. The advantages of
machine learning technique over simple visual inspection
include the extraction of various imaging features and
analysis of large amounts of quantitative imaging data
(“radiomics”). Utilization of machine learning technique
with multimodal imaging including high-resolution MRI
could be helpful in various stroke pathophysiologies.
However, it should be noted that machine learning may
be prone to misclassification errors in the case that some
patients’ images are degraded by motion. In this study,
we excluded a few patients whose GRE images were inad-
equate for analysis.
Stroke subtypes and related clot composition may
determine the response to recanalization therapy.33,41,42
Although cardioembolic stroke, especially in association
with atrial fibrillation, is the most common subtype in
patients with acute disabling ischemic stroke, patients
with other subtypes could be candidates for EVT.
Intracranial atherosclerosis is especially prevalent in
Asians and is associated with frequent EVT failure. In this
Table 2. Endovascular treatment procedures and outcome by presence
of atrial fibrillation.
Without atrial
fibrillation
(n = 38)
With atrial
fibrillation
(n = 29) P-value
Intravenous tPA before
procedure, n (%)
23 (60.5) 22 (75.9) 0.185
Treatment modality, n (%)
Stentriever 31 (81.6) 24 (82.8) 0.901
Stent 7 (18.4) 1 (3.4) 0.061
Glycogen IIb/IIIa blocker 11 (28.9) 2 (6.9) 0.024
Procedural event, median [IQR]
Number of retrieval passes 3 [3–4] 2 [1–3] <0.001
Number of reocclusions
during procedure
2 [0–4] 0 [0–0] <0.001
Total procedure time (min) 101.6  46.1 82.4  36.4 0.07
Procedural outcomes, n (%)
mTICI 2b or 3 16 (42.1) 21 (72.4) 0.013
by stentriever 3 (7.9) 19 (65.5) <0.001
by other modality
Stent 7 (18.4) 1 (3.4) 0.061
Glycogen IIb/IIIa
blocker
6 (15.8) 1 (3.4) 0.102
tPA, Tissue plasminogen activator; IQR, interquartile range; mTICI,
modified Treatment in Cerebral Infarction.
744 ª 2019 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals, Inc on behalf of American Neurological Association.
Machine Learning for Clot Analysis J.-W. Chung et al.
condition, adjuvant therapy, such as the use of a glycogen
IIb/IIIa inhibitor or rescue stent placement, may be
needed.43,44 Therefore, differentiation between intracranial
atherosclerotic and cardiogenic embolic occlusion using
pretreatment imaging data could help customize EVT.2 In
this study, the rate of successful recanalization with sten-
triever was lower in patients without atrial fibrillation and
additional recanalization was achieved using rescue stent-
ing and glycogen IIb/IIIa blocker treatment. In addition,
there were more retrieval passes and reocclusion episodes
and longer total procedure time in patients without atrial
fibrillation. Therefore, etiologic diagnosis of arterial
occlusion prior to EVT could be helpful in guiding EVT
strategies.
Study limitations
This study has several limitations. First, this was a single-
center study performed on a 3T scanner and a relatively
small number of patients were available for analysis. In
addition, only Korean patients were included for analyses.
Therefore, generalizability of the study findings may be
limited. Given that we used routine MRI data, our
method can be applied in the acute clinical setting, and
our results should prompt larger, multicenter, multieth-
nicity, confirmatory studies. Furthermore, GRE image uti-
lized in the study was not three-dimensional scans.
Future study with three-dimensional GRE image could
address partial volume effects with higher signal to noise
ratio. Second, clinicians would determine presence of
blooming artifact for standard of care, but neuroimaging
experts scored blooming artifact in this study. However,
this issue does not affect robustness of the study findings.
Third, even though MCA occlusion is the most common
reason for EVT, only MCA clots were analyzed and distal
internal carotid artery, MCA branch, and basilar artery
occlusions were excluded in this study. Further study is
needed to evaluate and validate the study findings in
other intracranial arteries. Fourth, GRE imaging used in
the present study was performed with 5-mm section
Figure 3. Representative cases of GRE vessel signal change after successful endovascular clot retrieval in atrial fibrillation and intracranial
atherosclerosis patients. (A) Clot signal analysis prior to endovascular thrombectomy showing “W” shaped signal intensity. (B) Retrieved red clots.
(C) Resolved “W” signal after successful removal of atrial fibrillation-related clot. (D) Clot signal analysis prior to endovascular thrombectomy
showing “non-W”-shaped signal intensity. (E) Retrieved white clots. (F) Heterogeneous dark signal after successful recanalization of atherosclerotic
occlusion with emergency stenting. GRE, gradient echo.
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thickness and interslice gap of 1.5 mm and was prone to
a partial volume effect. Therefore, precise quantitative
measurement of clot volume was not possible. Fifth, the
study finding was not confirmed with pathologic evalua-
tion. A prospective study with thrombus collection and
pathologic correlation is warranted to confirm that
machine learning-based noninvasive imaging analysis
could determine thrombus composition. However, analy-
sis of retrieved clot might not be the gold standard for
clot characterization, given the conflicting results for the
association between stroke subtype and histopathologic
data.18,45,46 Finally, due to the retrospective nature of the
study, we could not confirm whether EVT strategy selec-
tion based on clot characteristics could reduce procedure
time and increase the rate of successful recanalization.
Future study with a prospective design is warranted to
evaluate angiographic and clinical outcomes of clot char-
acter-based EVT.
Conclusion
Our data indicate that machine learning-based rapid and
noninvasive evaluation of clot characteristics is feasible
and could provide information on clot composition in
acute MCA occlusion patients. Further studies using mul-
timodal MRI and machine learning-based evaluation of
other stroke pathophysiologic factors, for example, collat-
eral circulation, blood–brain barrier, and tissue perfusion
status, and their association with EVT outcomes are
warranted.
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